論文

ページタイトル画像

2010年-2014年

  • 2014年
  • 2013年
  • 2012年
  • 2011年
  • 2010年

2014年

  1. Yamato M, Kanda T, Yasui S, Nakamura M, Miyamura T, Arai M, Maruyama H, Yokosuka O. [Pulmonary nocardiosis associated with the treatment of severe liver injury]. Nihon Shokakibyo Gakkai Zasshi. 2014 Feb;111(2):318-25.

  2. Tawada A, Kanda T, Oide T, Tsuyuguchi T, Imazeki F, Nakatani Y, Yokosuka O. 18F-fluorodeoxyglucose positron emission tomography might be useful for diagnosis of hepatic amyloidosis. Int Med Case Rep J. 2014 Jun 20;7:103-9.

  3. Nakagawa T, Katsuno T, Mandai Y, Saito M, Yoshihama S, Saito K, Minemura S, Maruoka D, Matsumura T, Arai M, Yokosuka O. A Case of Blind Loop Syndrome Caused by Infection with Giardia duodenalis Diagnosed with Double Balloon Enteroscopy. Case Rep Gastroenterol. 2014 Sep 23;8(3):276-81.

  4. Ooka Y, Chiba T, Ogasawara S, Arai K, Suzuki E, Tawada A, Yamashita T, Kanai F, Kaneko S, Yokosuka O. A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma. Invest New Drugs. 2014 Aug;32(4):723-8.

  5. Hayashi M, Kanda T, Nakamura M, Miyamura T, Yasui S, Nakamoto S, Wu S, Arai M, Imazeki F, Yokosuka O. Acute liver injury in a patient with alcohol dependence: a case resembling autoimmune hepatitis or drug-induced liver injury. Case Rep Gastroenterol. 2014 Apr 5;8(1):129-33.

  6. Kanda T, Jiang X, Yokosuka O. Androgen receptor signaling in hepatocellular carcinoma and pancreatic cancers. World J Gastroenterol. 2014 Jul 28;20(28):9229-36.

  7. Naito A, Terada J, Tanabe N, Sugiura T, Sakao S, Kanda T, Yokosuka O, Tatsumi K. Autoimmune hepatitis in a patient with pulmonary arterial hypertension treated with endothelin receptor antagonists. Intern Med. 2014;53(7):771-5.

  8. Seimiya M, Ohno S, Asano H, Fujiwara K, Yoshida T, Sawabe Y, Sogawa K, Ogawa M, Matsushita K, Yokosuka O, Nomura F. Change in albumin measurement method affects diagnosis of nephrotic syndrome. 2014Clin Lab. 2014;60(10):1663-7.

  9. Sakai Y, Tsuyuguchi T, Yokosuka O. Clinical usefulness and current problems of pancreatic duct stenting for preventing post-ERCP pancreatitis. World J Clin Cases. 2014 Sep 16;2(9):426-31.

  10. Motoyama T, Ogasawara S, Chiba T, Higashide T, Yokota H, Kanogawa N, Suzuki E, Ooka Y, Tawada A, Irie R, Ochi S, Masuda Y, Uno T, Yokosuka O. Coronal reformatted CT images contribute to the precise evaluation of the radiofrequency ablative margin for hepatocellular carcinoma. Abdom Imaging. 2014 Apr;39(2):262-8.

  11. Izumi N, Yokosuka O, Kawada N, Osaki Y, Yamamoto K, Sata M, Ishikawa H, Ueki T, Hu W, McPhee F, Hughes EA, Kumada H. Daclatasvir combined with peginterferon alfa-2a and ribavirin in Japanese patients infected with hepatitis C genotype 1. Antivir Ther. 2014;19(5):501-10.

  12. Chiba T, Suzuki E, Yuki K, Zen Y, Oshima M, Miyagi S, Saraya A, Koide S, Motoyama T, Ogasawara S, Ooka Y, Tawada A, Nakatsura T, Hayashi T, Yamashita T, Kaneko S, Miyazaki M, Iwama A, Yokosuka O. Disulfiram eradicates tumor-initiating hepatocellular carcinoma cells in ROS-p38 MAPK pathway-dependent and -independent manners. PLoS One. 2014 Jan 13;9(1):e84807.

  13. Tanaka T, Arai M, Jiang X, Sugaya S, Kanda T, Fujii K, Kita K, Sugita K, Imazeki F, Miyashita T, Kaneda A, Yokosuka O. Downregulation of microRNA-431 by human interferon-β inhibits viability of medulloblastoma and glioblastoma cells via upregulation of SOCS6. Int J Oncol. 2014 May;44(5):1685-90.

  14. Saito T, Chiba T, Suzuki E, Shinozaki M, Goto N, Kanogawa N, Motoyama T, Ogasawara S, Ooka Y, Tawada A, Kanda T, Miyazaki M, Yokosuka O. Effect of previous interferon-based therapy on recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma. Int J Med Sci. 2014 May 7;11(7):707-12.

  15. Fujiwara K, Yasui S, Yonemitsu Y, Mikata R, Arai M, Kanda T, Imazeki F, Oda S, Yokosuka O. Efficacy of high-dose corticosteroid in the early stage of viral acute liver failure. Hepatol Res. 2014 May;44(5):491-501.

  16. Ogasawara S, Chiba T, Ooka Y, Kanogawa N, Motoyama T, Suzuki E, Tawada A, Kanai F, Yoshikawa M, Yokosuka O. Efficacy of sorafenib in intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization. Oncology. 2014;87(6):330-41.

  17. Tawada A, Chiba T, Ooka Y, Kanogawa N, Motoyama T, Saito T, Ogasawara S, Suzuki E, Maruyama H, Kanai F, Yoshikawa M, Yokosuka O. Efficacy of transarterial chemoembolization targeting portal vein tumor thrombus in patients with hepatocellular carcinoma. Anticancer Res. 2014 Aug;34(8):4231-7.

  18. Sakai Y, Tsuyuguchi T, Kawaguchi Y, Hirata N, Nakaji S, Kitamura K, Mikami S, Fujimoto T, Ijima M, Kurihara E, Oana S, Nishino T, Tamura R, Sakamoto D, Nakamura M, Nishikawa T, Sugiyama H, Yoshida H, Mine T, Yokosuka O. Endoscopic papillary large balloon dilation for removal of bile duct stones. World J Gastroenterol. 2014 Dec 7;20(45):17148-54.

  19. Nishikawa T, Tsuyuguchi T, Ohyama H, Watanabe Y, Koseki H, Sakai Y, Sugiyama H, Sakamoto D, Kiyono S, Nakamura M, Yokosuka O. Endoscopy-guided laser lithotripsy for a difficult-to-crush enterolith. Gastrointest Endosc. 2014 Oct;80(4):729-730.

  20. Tanaka T, Arai M, Minemura S, Oyamada A, Saito K, Jiang X, Tsuboi M, Sazuka S, Maruoka D, Matsumura T, Nakagawa T, Sugaya S, Kanda T, Katsuno T, Kita K, Kishimoto T, Imazeki F, Kaneda A, Yokosuka O. Expression level of sonic hedgehog correlated with the speed of gastric mucosa regeneration in artificial gastric ulcers. J Gastroenterol Hepatol. 2014 Apr;29(4):736-41.

  21. Nishikawa T, Tsuyuguchi T, Sakai Y, Sugiyama H, Tawada K, Mikata R, Tada M, Ishihara T, Miyazaki M, Yokosuka O. Factors affecting the accuracy of endoscopic transpapillary sampling methods for bile duct cancer. Dig Endosc. 2014 Mar;26(2):276-81.

  22. Sazuka S, Katsuno T, Nakagawa T, Saito M, Saito K, Maruoka D, Matsumura T, Arai M, Miyauchi H, Matsubara H, Yokosuka O. Fibrocytes are involved in inflammation as well as fibrosis in the pathogenesis of Crohn's disease. Dig Dis Sci. 2014 Apr;59(4):760-8.

  23. Sekimoto T, Maruyama H, Kiyono S, Kondo T, Shimada T, Ishibashi H, Takahashi M, Yokosuka O, Yamaguchi T. Hepatic filling rate of a microbubble agent: a novel predictor of long-term outcomes in patients with cirrhosis. b Ultrasound Med Biol. 2014 Sep;40(9):2082-8.

  24. Jiang X, Kanda T, Wu S, Nakamoto S, Wakita T, Shirasawa H, Yokosuka O. Hepatitis C virus nonstructural protein 5A inhibits thapsigargin-induced apoptosis. PLoS One. 2014 Nov 19;9(11):e113499.

  25. Nakamoto S, Kanda T, Wu S, Shirasawa H, Yokosuka O. Hepatitis C virus NS5A inhibitors and drug resistance mutations. World J Gastroenterol. 2014 Mar 21;20(11):2902-12.

  26. Fujiwara K, Yasui S, Yokosuka O. Historical, present, and future significance of corticosteroid in the treatment of acute liver failure. Hepatology. 2014 Oct;60(4):1447-8.

  27. Miyamura T, Kanda T, Nakamoto S, Arai M, Nakamura M, Wu S, Jiang X, Sasaki R, Haga Y, Yasui S, Ooka Y, Chiba T, Imazeki F, Mikami S, Yokosuka O. IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens. Int J Hepatol. 2014;2014:723868.

  28. Liu Y, Sogawa K, Sunaga M, Umemura H, Satoh M, Kazami T, Yoshikawa M, Tomonaga T, Yokosuka O, Nomura F. Increased concentrations of apo A-I and apo A-II fragments in the serum of patients with hepatocellular carcinoma by magnetic beads-assisted MALDI-TOF mass spectrometry. Am J Clin Pathol. 2014 Jan;141(1):52-61.

  29. Kondo T, Maruyama H, Sekimoto T, Shimada T, Takahashi M, Okugawa H, Yokosuka O, Yamaguchi T. Influence of paraumbilical vein patency on the portal hemodynamics of patients with cirrhosis. J Clin Gastroenterol. 2014 Feb;48(2):178-83.

  30. Tawada A, Chiba T, Ooka Y, Yokota H, Kanogawa N, Motoyama T, Saito T, Ogasawara S, Suzuki E, Hanari N, Matsubara H, Saeki N, Kambe M, Kishimoto T, Nakatani Y, Yokosuka O. Intracranial metastasis in a patient with hepatocellular carcinoma and gastric cancer. Case Rep Oncol. 2014 Mar 14;7(1):199-203.

  31. Ohtsuka M, Shimizu H, Kato A, Yoshitomi H, Furukawa K, Tsuyuguchi T, Sakai Y, Yokosuka O, Miyazaki M. Intraductal papillary neoplasms of the bile duct. Int J Hepatol. 2014;2014:459091.

  32. Jiang X, Kanda T, Nakamoto S, Miyamura T, Wu S, Yokosuka O. Involvement of androgen receptor and glucose-regulated protein 78 kDa in human hepatocarcinogenesis. Exp Cell Res. 2014 May 1;323(2):326-36.

  33. Ogasawara S, Chiba T, Ooka Y, Kanogawa N, Motoyama T, Suzuki E, Tawada A, Yokosuka O. Is intra-patient sorafenib dose re-escalation safe and tolerable in patients with advanced hepatocellular carcinoma? Int J Clin Oncol. 2014 Dec;19(6):1029-36.

  34. Jiang X, Kanda T, Nakamoto S, Haga Y, Sasaki R, Nakamura M, Wu S, Mikata R, Yokosuka O. Knockdown of glucose-regulated protein 78 enhances poly(ADP-ribose) polymerase cleavage in human pancreatic cancer cells exposed to endoplasmic reticulum stress. Oncol Rep. 2014 Dec;32(6):2343-8.

  35. Maruyama H, Takahashi M, Sekimoto T, Shimada T, Yokosuka O. Linoleate appears to protect against palmitate-induced inflammation in Huh7 cells. Lipids Health Dis. 2014 May 13;13:78.

  36. Kondo T, Maruyama H, Sekimoto T, Shimada T, Takahashi M, Chiba T, Kanai F, Yokosuka O, Yamaguchi T. Natural history of postvascular-phase iso-enhanced lesions on the sonogram in chronic liver diseases. J Gastroenterol Hepatol. 2014 Jan;29(1):165-72.

  37. Kanda T, Nakamoto S, Wu S, Yokosuka O. New treatments for genotype 1 chronic hepatitis C - focus on simeprevir. Ther Clin Risk Manag. 2014 May 24;10:387-94.

  38. Kanda T, Nakamoto S, Yasui S, Nakamura M, Miyamura T, Wu S, Jiang X, Arai M, Imazeki F, Yokosuka O. Occurrence and Recurrence of Hepatocellular Carcinoma Were Not Rare Events during Phlebotomy in Older Hepatitis C Virus-Infected Patients. Case Rep Oncol. 2014 May 8;7(2):288-96.

  39. Nishikawa T, Tsuyuguchi T, Sakai Y, Sugiyama H, Sakamoto D, Nakamura M, Yokosuka O. Old age is associated with increased severity of complications in endoscopic biliary stone removal. Dig Endosc. 2014 Jul;26(4):569-76.

  40. Ooka Y, Chiba T, Ogasawara S, Motoyama T, Suzuki E, Tawada A, Kanai F, Yokosuka O. Partial splenic embolization with transarterial chemoembolization in patients with hepatocellular carcinoma accompanied by thrombocytopenia. Biomed Res Int. 2014;2014:960628.

  41. Kondo R, Nakashima O, Sata M, Imazeki F, Yokosuka O, Tanikawa K, Kage M, Yano H; The Liver Cancer Study Group of Kyushu. Pathological characteristics of patients who develop hepatocellular carcinoma with negative results of both serous hepatitis B surface antigen and hepatitis C virus antibody. Hepatol Res. 2014 Oct;44(11):1039-46.

  42. Matsumura T, Arai M, Saito K, Okimoto K, Saito M, Minemura S, Oyamada A, Maruoka D, Nakagawa T, Watabe H, Katsuno T, Yokosuka O. Predictive factor of re-bleeding after negative capsule endoscopy for obscure gastrointestinal bleeding: over 1-year follow-up study. Dig Endosc. 2014 Sep;26(5):650-8.

  43. Nishikawa T, Tsuyuguchi T, Sakai Y, Sugiyama H, Kishimoto T, Ohtsuka M, Miyazaki M, Yokosuka O. Preoperative assessment of longitudinal extension of cholangiocarcinoma with peroral video-cholangioscopy: a prospective study. Dig Endosc. 2014 May;26(3):450-7.

  44. Hosokawa I, Shimizu H, Ohtsuka M, Kato A, Yoshitomi H, Furukawa K, Takayashiki T, Ishihara T, Yokosuka O, Miyazaki M. Preoperative diagnosis and surgical management for solid pseudopapillary neoplasm of the pancreas. J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):573-8.

  45. Fujiwara K, Ohtsuka M, Yokosuka O. Radiologic and histologic heterogeneity in a case of autoimmune acute liver failure. Clin Gastroenterol Hepatol. 2014 Mar;12(3):e19-20.

  46. Sudo K, Ishihara T, Hirata N, Ozawa F, Ohshima T, Azemoto R, Shimura K, Nihei T, Nishino T, Nakagawa A, Nakamura K, Hara T, Tada M, Mikata R, Tawada K, Yokosuka O, Nakaji S, Yamaguchi T. Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer. Cancer Chemother Pharmacol. 2014 Feb;73(2):389-96.

  47. Nakamoto S, Kanda T, Nakaseko C, Sakaida E, Ohwada C, Takeuchi M, Takeda Y, Mimura N, Iseki T, Wu S, Arai M, Imazeki F, Saito K, Shirasawa H, Yokosuka O. Reactivation of hepatitis B virus in hematopoietic stem cell transplant recipients in Japan: efficacy of nucleos(t)ide analogues for prevention and treatment. Int J Mol Sci. 2014 Nov 21;15(11):21455-67.

  48. Jiang X, Kanda T, Wu S, Nakamura M, Miyamura T, Nakamoto S, Banerjee A, Yokosuka O. Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity. World J Gastroenterol. 2014 Jun 21;20(23):7197-206.

  49. Matsumura T, Arai M, Maruoka D, Okimoto K, Minemura S, Ishigami H, Saito K, Nakagawa T, Katsuno T, Yokosuka O. Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents. BMC Gastroenterol. 2014 Oct 3;14:172.

  50. Nishikawa T, Tsuyuguchi T, Sakai Y, Yokosuka O. Safe recovery of a fully fractured basket in the bile duct using endoscopic papillary large balloon dilation. Endoscopy. 2014;46 Suppl 1 UCTN:E365-6.

  51. Maruyama H, Kiyono S, Kamesaki H, Kondo T, Sekimoto T, Yokosuka O. Saline-enhanced ultrasonography: prediction of X-ray appearance of hepatic venography in patients with cirrhosis. Scand J Gastroenterol. 2014 May;49(5):625-31.

  52. Saito K, Katsuno T, Nakagawa T, Minemura S, Oyamada A, Kanogawa N, Saito M, Yoshihama S, Maruoka D, Matsumura T, Arai M, Tohma T, Miyauchi H, Matsubara H, Yokosuka O. Severe diffuse duodenitis successfully treated with intravenous tacrolimus after colectomy for ulcerative colitis. Intern Med. 2014;53(21):2477-81.

  53. Kondo T, Maruyama H, Kiyono S, Sekimoto T, Shimada T, Takahashi M, Okugawa H, Kobayashi S, Yoshizumi H, Yokosuka O. Similarities and differences in the clinical features between cardia varices and esophageal varices. J Gastroenterol Hepatol. 2014 Nov;29(11):1911-8.

  54. Omata M, Nishiguchi S, Ueno Y, Mochizuki H, Izumi N, Ikeda F, Toyoda H, Yokosuka O, Nirei K, Genda T, Umemura T, Takehara T, Sakamoto N, Nishigaki Y, Nakane K, Toda N, Ide T, Yanase M, Hino K, Gao B, Garrison KL, Dvory-Sobol H, Ishizaki A, Omote M, Brainard D, Knox S, Symonds WT, McHutchison JG, Yatsuhashi H, Mizokami M. Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial. J Viral Hepat. 2014 Nov;21(11):762-8.

  55. Maruyama H, Kamezaki H, Kondo T, Sekimoto T, Takahashi M, Yokosuka O. Sonographic and clinical features of collateral vessels at the splenic hilum in cirrhosis. Clin Radiol. 2014 Mar;69(3):e140-5.

  56. Kanogawa N, Chiba T, Ogasawara S, Ooka Y, Suzuki E, Motoyama T, Saito T, Sekimoto T, Tawada A, Maruyama H, Yoshikawa M, Yokosuka O. Successful interventional treatment for arterioportal fistula caused by radiofrequency ablation for hepatocellular carcinoma. Case Rep Oncol. 2014 Dec 19;7(3):833-9.

  57. Jiang X, Kanda T, Wu S, Nakamoto S, Saito K, Shirasawa H, Kiyohara T, Ishii K, Wakita T, Okamoto H, Yokosuka O. Suppression of La antigen exerts potential antiviral effects against hepatitis A virus. PLoS One. 2014 Jul 7;9(7):e101993.

  58. Tsuyuguchi T, Miyakawa K, Sugiyama H, Sakai Y, Nishikawa T, Sakamoto D, Nakamura M, Yasui S, Mikata R, Yokosuka O. Ten-year long-term results after non-surgical management of hepatolithiasis, including cases with choledochoenterostomy. J Hepatobiliary Pancreat Sci. 2014 Nov;21(11):795-800.

  59. Maruyama H, Kamezaki H, Takahashi M, Okugawa H, Yokosuka O. The potential of transabdominal 3D color doppler ultrasonography for diagnosis of gastric varices. J Clin Gastroenterol. 2014 Aug;48(7):629-34.

  60. Arai M, Matsumura T, Okimoto K, Oyamada A, Saito K, Minemura S, Maruoka D, Tanaka T, Nakagawa T, Katsuno T, Yokosuka O. Two-week treatment with proton pump inhibitor is sufficient for healing post endoscopic submucosal dissection ulcers. World J Gastroenterol. 2014 Nov 21;20(43):16318-22.

  61. McPhee F, Hernandez D, Zhou N, Yu F, Ueland J, Monikowski A, Chayama K, Toyota J, Izumi N, Yokosuka O, Kawada N, Osaki Y, Hughes EA, Watanabe H, Ishikawa H, Kumada H. Virological escape in HCV genotype-1-infected patients receiving daclatasvir plus ribavirin and peginterferon alfa-2a or alfa-2b. Antivir Ther. 2014;19(5):479-90.

2013年

  1. Minemura S, Matsumura T, Arai M, Oyamada A, Saito K, Sazuka S, Tsuboi M, Maruoka D, Tanaka T, Nakagawa T, Katsuno T, Ishida K, Matsumiya G, Yokosuka O. A primary arterio enteric fistula with Takayasu arteritis. Intern Med. 2013;52(3):359-62.

  2. Miyamura T, Kanda T, Minemura S, Nakamura M, Nakamoto S, Jiang X, Wu S, Yasui S, Arai M, Yokosuka O. Acute liver failure associated with propylthiouracil in a pregnant 26-year-old woman. Case Rep Gastroenterol. 2013 May 25;7(2):240-4.

  3. Kanogawa N, Kanda T, Ohtsuka M, Nakamura M, Miyamura T, Yasui S, Arai M, Maruyama H, Fujiwara K, Shozu M, Oda S, Miyazaki M, Yokosuka O. Acute Liver Failure Occurring during the First Trimester of Pregnancy Successfully Treated with Living Donor Liver Transplantation. Case Rep Transplant. 2013;2013:309545.

  4. Kamezaki H, Kanda T, Arai M, Wu S, Nakamoto S, Chiba T, Maruyama H, Fujiwara K, Kanai F, Imazeki F, Nomura F, Yokosuka O. Adherence to medication is a more important contributor to viral breakthrough in chronic hepatitis B patients treated with entecavir than in those with Lamivudine. Int J Med Sci. 2013;10(5):567-74.

  5. Nakamura M, Kanda T, Miyamura T, Wu S, Nakamoto S, Yokosuka O. Alanine aminotransferase elevation during peginterferon alpha-2a or alpha-2b plus ribavirin treatment. Int J Med Sci. 2013 Jun 15;10(8):1015-21.

  6. Kanda T, Yokosuka O, Omata M. Antiviral therapy for "difficult-to-treat" hepatitis C virus-infected patients. Chin Med J (Engl). 2013 Dec;126(23):4568-74.

  7. Sakai Y, Tsuyuguchi T, Hirata N, Nakaji S, Shimura K, Fujimoto T, Tsuchiya S, Nishino T, Nishikawa T, Sugiyama H, Yokosuka O. Can endoscopic sphincterotomy be performed safely in elderly patients aged 80 years or older with pancreatic and biliary diseases? Hepatogastroenterology. 2013 Sep;60(126):1251-6.

  8. Matsumura T, Arai M, Yoshikawa M, Sudo K, Nakamura K, Katsuno T, Kanai F, Yamaguchi T, Yokosuka O. Changes in plasma ghrelin and serum leptin levels after Cisplatin-based transcatheter arterial infusion chemotherapy for hepatocellular carcinoma. ISRN Gastroenterol. 2013;2013:415450.

  9. Takahashi M, Maruyama H, Shimada T, Kamezaki H, Sekimoto T, Kanai F, Yokosuka O. Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging. Eur J Radiol. 2013 Jan;82(1):75-84.

  10. Seimiya M, Ohno S, Yamamoto H, Fujiwara K, Yoshida T, Sawabe Y, Sogawa K, Matsushita K, Yokosuka O, Nomura F. Child-Pugh score is altered by the albumin measurement method. Hepatology. 2013 May;57(5):2093-4.

  11. Chiba T, Kanai F, Iwama A, Yokosuka O. Circulating cancer stem cells: a novel prognostic predictor of hepatocellular carcinoma. Hepatobiliary Surg Nutr. 2013 Feb;2(1):4-6.

  12. Sato A, Sata M, Ikeda K, Kumada T, Izumi N, Asahina Y, Osaki Y, Chayama K, Kaneko S, Sakai A, Onji M, Hiasa Y, Omura T, Ozeki I, Yokosuka O, Shiina S, Itsubo M, Nishiguchi S, Hirano K, Ide T, Sakisaka S, Yamasaki T, Hidaka I, Tanaka M, Kim SR, Ichida T. Clinical characteristics of patients who developed hepatocellular carcinoma after hepatitis C virus eradication with interferon therapy: current status in Japan. Intern Med. 2013;52(24):2701-6.

  13. Maruoka D, Arai M, Kishimoto T, Matsumura T, Inoue M, Nakagawa T, Watanabe Y, Katsuno T, Tsuyuguchi T, Imazeki F, Yokosuka O. Clinical outcomes of endoscopic resection for nonampullary duodenal high-grade dysplasia and intramucosal carcinoma. Endoscopy. 2013;45(2):138-41.

  14. Hata S, Arai M, Suzuki T, Maruoka D, Matsumura T, Nakagawa T, Katsuno T, Imazeki F, Yokosuka O. Clinical significance of endoscopic ultrasound for gastric submucosal tumors. Clin Res Hepatol Gastroenterol. 2013 Apr;37(2):207-12.

  15. Sakai Y, Tsuyuguchi T, Kato K, Sugiyama H, Nishikawa T, Takahashi M, Yokosuka O. Clinical usefulness of doripenem (DRPM), a carbapenem antimicrobial drug, for the treatment of patients with acute cholangitis: retrospective study. Int J Clin Pharmacol Ther. 2013 Jan;51(1):19-25.

  16. Mikata R, Ishihara T, Tada M, Tawada K, Saito M, Kurosawa J, Sugiyama H, Sakai Y, Tsuyuguchi T, Miyazaki M, Yokosuka O. Clinical usefulness of repeated pancreatic juice cytology via endoscopic naso-pancreatic drainage tube in patients with pancreatic cancer. J Gastroenterol. 2013 Jul;48(7):866-73.

  17. Tawada K, Ishihara T, Yamaguchi T, Tsuyuguchi T, Hara T, Tada M, Mikata R, Sakai Y, Sugiyama H, Saito M, Kurosawa J, Nishikawa T, Yoshitomi H, Ohtsuka M, Miyazaki M, Yokosuka O. Comparison of branch duct and main pancreatic duct mural nodules in intraductal papillary mucinous neoplasm. Pancreas. 2013 Oct;42(7):1193-5.

  18. Nishikawa T, Tsuyuguchi T, Sakai Y, Sugiyama H, Miyazaki M, Yokosuka O. Comparison of the diagnostic accuracy of peroral video-cholangioscopic visual findings and cholangioscopy-guided forceps biopsy findings for indeterminate biliary lesions: a prospective study. Gastrointest Endosc. 2013 Feb;77(2):219-26.

  19. Fujiwara K, Yasui S, Yokosuka O. Corticosteroid for severe acute exacerbation of chronic hepatitis B. Eur J Gastroenterol Hepatol. 2013 Dec;25(12):1492.

  20. Maruyama H, Okugawa H, Takahashi M, Yokosuka O. De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol. 2013 Apr;108(4):568-74.

  21. Kanda T, Jiang X, Nakamoto S, Nakamura M, Miyamura T, Wu S, Yokosuka O. Different effects of three interferons L on Toll-like receptor-related gene expression in HepG2 cells. Cytokine. 2013 Nov;64(2):577-83.

  22. Mandai Y, Takahashi D, Hase K, Obata Y, Furusawa Y, Ebisawa M, Nakagawa T, Sato T, Katsuno T, Saito Y, Shimaoka T, Yokosuka O, Yokote K, Ohno H. Distinct Roles for CXCR6(+) and CXCR6(-) CD4(+) T Cells in the Pathogenesis of Chronic Colitis. PLoS One. 2013 Jun 19;8(6):e65488.

  23. Kitazono S, Takiguchi Y, Ashinuma H, Saito-Kitazono M, Kitamura A, Chiba T, Sakaida E, Sekine I, Tada Y, Kurosu K, Sakao S, Tanabe N, Iwama A, Yokosuka O, Tatsumi K. Effect of metformin on residual cells after chemotherapy in a human lung adenocarcinoma cell line. Int J Oncol. 2013 Dec;43(6):1846-54.

  24. Nakano M, Kawaguchi T, Nakamoto S, Kawaguchi A, Kanda T, Imazeki F, uromatsu R, Sumie S, Satani M, Yamada S, Torimura T, Kakuma T, Yokosuka O, Sata M. Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection. Oncol Rep. 2013 Nov;30(5):2049-55.

  25. Maruyama H, Kamezaki H, Kondo T, Sekimoto T, Shimada T, Takahashi M, Okugawa H, Yokosuka O. Effects of inferior mesenteric vein flow in patients with cirrhosis. Clin Gastroenterol Hepatol. 2013 Dec;11(12):1648-54.

  26. Miyauchi T, Kanda T, Shinozaki M, Kamezaki H, Wu S, Nakamoto S, Kato K, Arai M, Mikami S, Sugiura N, Kimura M, Goto N, Imazeki F, Yokosuka O. Efficacy of lamivudine or entecavir against virological rebound after achieving HBV DNA negativity in chronic hepatitis B patients. Int J Med Sci. 2013;10(6):647-52.

  27. Okimoto K, Ogasawara S, Chiba T, Ooka Y, Oobu M, Azemoto R, Kanogawa N, Motoyama T, Suzuki E, Tawada A, Yoshikawa M, Yokosuka O. Efficacy of transcatheter arterial chemoembolization with miriplatin-lipiodol water-soluble contrast agent emulsion in patients with hepatocellular carcinoma. Anticancer Res. 2013 Dec;33(12):5603-9.

  28. Sakai Y, Tsuyuguchi T, Sugiyama H, Nishikawa T, Kurosawa J, Saito M, Tawada K, Mikata R, Tada M, Ishihara T, Yokosuka O. Endoscopic sphincterotomy combined with large balloon dilation for removal of large bile duct stones. Hepatogastroenterology. 2013 Jan-Feb;60(121):58-64.

  29. Ooka Y, Kanai F, Okabe S, Ueda T, Shimofusa R, Ogasawara S, Chiba T, Sato Y, Yoshikawa M, Yokosuka O. Gadoxetic acid-enhanced MRI compared with CT during angiography in the diagnosis of hepatocellular carcinoma. Magn Reson Imaging. 2013 Jun;31(5):748-54.

  30. Wu S, Kanda T, Nakamoto S, Imazeki F, Yokosuka O. Hepatitis C virus protease inhibitor-resistance mutations: our experience and review. World J Gastroenterol. 2013 Dec 21;19(47):8940-8.

  31. Sakai Y, Tsuyuguchi T, Sugiyama H, Nishikawa T, Kurosawa J, Saito M, Tawada K, Mikata R, Tada M, Ishihara T, Yokosuka O. Hypertonic saline-epinephrine local injection therapy for post-endoscopic sphincterotomy bleeding: removal of blood clots using pure ethanol local injection. Surg Laparosc Endosc Percutan Tech. 2013 Aug;23(4):e156-9.

  32. Miyamura T, Kanda T, Nakamura M, Jiang X, Wu S, Nakamoto S, Mikami S, Takada N, Imazeki F, Yokosuka O. IL-28B polymorphisms and treatment response in hepatitis C virus patients with persistently normal alanine aminotransferase. World J Hepatol. 2013 Nov 27;5(11):635-41.

  33. Izumi N, Asahina Y, Kurosaki M, Yamada G, Kawai T, Kajiwara E, Okamura Y, Takeuchi T, Yokosuka O, Kariyama K, Toyoda J, Inao M, Tanaka E, Moriwaki H, Adachi H, Katsushima S, Kudo M, Takaguchi K, Hiasa Y, Chayama K, Yatsuhashi H,Oketani M, Kumada H. Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study. J Gastroenterol. 2013 Mar;48(3):382-90.

  34. Hata S, Arai M, Maruoka D, Tanaka T, Matsumura T, Suzuki T, Nakagawa T, Katsuno T, Imazeki F, Yokosuka O. Intragastric acidity during the first day following administration of low-dose proton pump inhibitors: a randomized crossover study. Clin Res Hepatol Gastroenterol. 2013 Jun;37(3):296-301.

  35. Katsuno T, Saito K, Yokosuka O. Letter: factors that may predict response to ciclosporin in ulcerative colitis - authors' reply. Aliment Pharmacol Ther. 2013 Mar;37(6):655.

  36. Katsuno T, Saito K, Yokosuka O. Letter: should colectomy be the end-point to evaluate the effectiveness of drug therapies in severe ulcerative colitis? Authors' reply. Aliment Pharmacol Ther. 2013 Jan;37(1):161.

  37. Fujiwara K, Yasui S, Yokosuka O. Letter: treatment of autoimmune acute liver failure--beyond consensus guidelines. Aliment Pharmacol Ther. 2013 Nov;38(9):1143-4.

  38. Jiang X, Kanda T, Tanaka T, Wu S, Nakamoto S, Imazeki F, Yokosuka O. Lipopolysaccharide blocks induction of unfolded protein response in human hepatoma cell lines. Immunol Lett. 2013 Apr;152(1):8-15.

  39. Sakai Y, Tsuyuguchi T, Hirata N, Sugiyama H, Shimura K, Nakaji S, Shiratori T, Fujimoto T, Tsuchiya S, Mikami S, Yokosuka O. Long term outcome of the WallFlex partially covered stent for unresectable malignant biliary obstruction: a multicenter single-arm prospective study. Hepatogastroenterology. 2013 Oct 2;60(128).

  40. Saito T, Chiba T, Yuki K, Zen Y, Oshima M, Koide S, Motoyama T, Ogasawara S, Suzuki E, Ooka Y, Tawada A, Tada M, Kanai F, Takiguchi Y, Iwama A, Yokosuka O. Metformin, a diabetes drug, eliminates tumor-initiating hepatocellular carcinoma cells. PLoS One. 2013 Jul 29;8(7)

  41. Nakamura M, Kanda T, Nakamoto S, Miyamura T, Jiang X, Wu S, Yokosuka O. No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV. PLoS One. 2013 Dec 11;8(12):e81312.

  42. Suzuki E, Chiba T, Yokosuka O. Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med. 2013 Sep 19;369(12):1170-1.

  43. Kanda T, Nakamoto S, Nishino T, Takada N, Tsubota A, Kato K, Miyamura T, Maruoka D, Wu S, Tanaka T, Arai M, Mikami S, Fujiwara K, Imazeki F, Yokosuka O. Peginterferon Alfa-2a plus ribavirin in Japanese patients infected with hepatitis C virus genotype 2 who failed previous interferon therapy. Int J Med Sci. 2013;10(1):43-9.

  44. Kanda T, Kato K, Tsubota A, Takada N, Nishino T, Mikami S, Miyamura T, Maruoka D, Wu S, Nakamoto S, Arai M, Fujiwara K, Imazeki F, Yokosuka O. Platelet count and sustained virological response in hepatitis C treatment. World J Hepatol. 2013 Apr 27;5(4):182-8.

  45. Sugiyama H, Tsuyuguchi T, Sakai Y, Nisikawa T, Miyazaki M, Yokosuka O. Preoperative Drainage for Distal Biliary Obstruction: Endoscopic Stenting or Nasobiliary Drainage? Hepatogastroenterology. 2013 Mar-Apr;60(122):231-4.

  46. Maruyama H, Takahashi M, Shimada T, Sekimoto T, Kamesaki H, Kanai F, Yokosuka O. Pretreatment microbubble-induced enhancement in hepatocellular carcinoma predicts intrahepatic distant recurrence after radiofrequency ablation. AJR Am J Roentgenol. 2013 Mar;200(3):570-7.

  47. Wu S, Kanda T, Nakamoto S, Jiang X, Miyamura T, Nakatani SM, Ono SK, Takahashi-Nakaguchi A, Gonoi T, Yokosuka O. Prevalence of hepatitis C virus subgenotypes 1a and 1b in Japanese patients: ultra-deep sequencing analysis of HCV NS5B genotype-specific region. PLoS One. 2013 Sep 17;8(9):e73615.

  48. Yamamoto K, Miyake Y, Ohira H, Suzuki Y, Zeniya M, Onji M, Tsubouchi H; the Intractable Liver and Biliary Diseases Study Group of Japan. Prognosis of autoimmune hepatitis showing acute presentation. Hepatol Res. 2013 Jun;43(6):630-8.

  49. Sogawa K, Noda K, Umemura H, Seimiya M, Kuga T, Tomonaga T, Nishimura M, Kanai F, Imazeki F, Takizawa H, Yoneda M, Nakajima A, Tsutsumi M, Yokosuka O, Nomura F. Serum fibrinogen alpha C-chain 5.9 kDa fragment as a biomarker for early detection of hepatic fibrosis related to hepatitis C virus. Proteomics Clin Appl. 2013 Jun;7(5-6):424-31.

  50. Haga Y, Chiba T, Ohira G, Kanai F, Yokota H, Motoyama T, Ogasawara S, Suzuki E, Ooka Y, Tawada A, Miyauchi H, Matubara H, Yokosuka O. Simultaneous resection of disseminated hepatocellular carcinoma and colon cancer. Case Rep Gastroenterol. 2013 Jan;7(1):37-43.

  51. Motoyama T, Ogasawara S, Chiba T, Suzuki E, Yokota H, Haga Y, Kanogawa N, Saito T, Ooka Y, Tawada A, Kanai F, Yokosuka O. Successful non-surgical treatment of ruptured pyogenic liver abscess. Intern Med. 2013;52(23):2619-22.

  52. Okimoto K, Ogasawara S, Chiba T, Kanai F, Yokota H, Motoyama T, Suzuki E, Ooka Y, Tawada A, Iwadate Y, Saeki N, Yokosuka O. Successful resection of intracranial metastasis of hepatocellular carcinoma. Case Rep Gastroenterol. 2013 Mar 28;7(1):182-7.

  53. Suzuki Y, Ohtake T, Nishiguchi S, Hashimoto E, Aoyagi Y, Onji M, Kohgo Y; The Japan Non-B, Non-C Liver Cirrhosis Study Group. Survey of non-B, non-C liver cirrhosis in Japan. Hepatol Res. 2013 Oct;43(10):1020-31.

  54. Semba T, Nishimura M, Nishimura S, Ohara O, Ishige T, Ohno S, Nonaka K, Sogawa K, Satoh M, Sawai S, Matsushita K, Imazeki F, Yokosuka O, Nomura F. The FLS (fatty liver Shionogi) mouse reveals local expressions of lipocalin-2, CXCL1 and CXCL9 in the liver with non-alcoholic steatohepatitis. BMC Gastroenterol. 2013 Jul 23;13:120.

  55. Kanda T, Yokosuka O, Omata M. Treatment of hepatitis C virus infection in the future. Clin Transl Med. 2013 Apr 11;2(1):9.

  56. Wu S, Nakamoto S, Kanda T, Jiang X, Nakamura M, Miyamura T, Shirasawa H, Sugiura N, Takahashi-Nakaguchi A, Gonoi T, Yokosuka O. Ultra-deep sequencing analysis of the hepatitis A virus 5'-untranslated region among cases of the same outbreak from a single source. Int J Med Sci. 2013 Dec 20;11(1):60-4.

  57. Saito M, Ishihara T, Tada M, Tsuyuguchi T, Mikata R, Sakai Y, Tawada K, Sugiyama H, Kurosawa J, Otsuka M, Uchida Y, Uchiyama K, Miyazaki M, Yokosuka O. Use of F-18 fluorodeoxyglucose positron emission tomography with dual-phase I maging to identify intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol. 2013 Feb;11(2):181-6.

  58. Tsuboi M, Arai M, Maruoka D, Matsumura T, Nakagawa T, Katsuno T, Yokosuka O. Utility and stability of transnasal endoscopy for examination of the pharynx - a prospective study and comparison with transoral endoscopy. Int J Med Sci. 2013 Jul 3;10(9):1085-91.

  59. Tsuboi M, Arai M, Maruoka D, Matsumura T, Nakagawa T, Katsuno T, Yokosuka O. Utility of unsedated transnasal endoscopy for pharyngeal observation during esophagogastroduodenoscopy. A prospective study to assess cardiopulmonary function. Scand J Gastroenterol. 2013 Jul;48(7):884-9.

  60. Sekimoto T, Maruyama H, Kondo T, Shimada T, Takahashi M, Yokosuka O, Otsuka M, Miyazaki M, Mine Y. Virtual laparoscopy: Initial experience with three-dimensional ultrasonography to characterize hepatic surface features. Eur J Radiol. 2013 Jun;82(6):929-34.

2012年

  1. Chiba T, Suzuki E, Negishi M, Saraya A, Miyagi S, Konuma T, Tanaka S, Tada M, Kanai F, Imazeki F, Iwama A, Yokosuka O. 3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells. Int J Cancer. 2012 Jun 1;130(11):2557-67.

  2. Wakamatsu T, Kanda T, Tawada A, Miyamura T, Takahashi M, Chiba T, Arai M, Maruyama H, Fujiwara K, Imazeki F, Yokosuka O. Acute liver failure in an antimitochondrial antibody-positive 63-year-old man. Case Rep Gastroenterol. 2012 May;6(2):394-9.

  3. Suzuki E, Chiba T, Zen Y, Miyagi S, Tada M, Kanai F, Imazeki F, Miyazaki M, Iwama A, Yokosuka O. Aldehyde dehydrogenase 1 is associated with recurrence-free survival but not stem cell-like properties in hepatocellular carcinoma. Hepatol Res. 2012 Nov;42(11):1100-11.

  4. Ashinuma H, Takiguchi Y, Kitazono S, Kitazono-Saitoh M, Kitamura A, Chiba T, Tada Y, Kurosu K, Sakaida E, Sekine I, Tanabe N, Iwama A, Yokosuka O, Tatsumi K. Antiproliferative action of metformin in human lung cancer cell lines. Oncol Rep. 2012 Jul;28(1):8-14.

  5. Abe K, Katsushima F, Kanno Y, Takahashi A, Yokokawa J, Ohira H, Arinaga T, Ide T, Nishimura J, Inoue M, Seike M, Imazeki F, Yokosuka O, Sata  M. Clinical features of cirrhosis in Japanese patients with type I autoimmune hepatitis. Intern Med. 2012;51(24):3323-8.

  6. Matsumoto A, Tanaka E, Suzuki Y, Kobayashi M, Tanaka Y, Shinkai N, Hige S, Yatsuhashi H, Nagaoka S, Chayama K, Tsuge M, Yokosuka O, Imazeki F, Nishiguchi S, Saito M, Fujiwara K, Torii N, Hiramatsu N, Karino Y, Kumada H. Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B. Hepatol Res. 2012 Feb;42(2):139-149.

  7. Sazuka S, Katsuno T, Nakagawa T, Saito M, Saito K, Matsumura T, Arai M, Sato T, Yokosuka O. Concomitant use of enteral nutrition therapy is associated with sustained response to infliximab in patients with Crohn's disease. Eur J Clin Nutr. 2012 Nov;66(11):1219-23.

  8. Maruyama H, Takahashi M, Ishibashi H, Yoshikawa M, Yokosuka O. Contrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases. Br J Radiol. 2012 Apr;85(1012):351-7.

  9. Maruyama H, Yokosuka O. Contrast-enhanced Ultrasound for Non-tumor Liver Diseases. JNMA J Nepal Med Assoc. 2012 Jan-Mar;52(185):43-8.

  10. Sakai Y, Tsuyuguchi T, Sugiyama H, Nishikawa T, Tawada K, Saito M, Kurosawa J, Mikata R, Tada M, Ishihara T, Yokosuka O. Current situation of endoscopic treatment for common bile duct stones. Hepatogastroenterology. 2012 Sep;59(118):1712-6.

  11. Maruyama H, Shimada T, Ishibashi H, Takahashi M, Kamesaki H, Yokosuka O. Delayed periportal enhancement: a characteristic finding on contrast ultrasound in idiopathic portal hypertension. Hepatol Int. 2012 Apr;6(2):511-9.

  12. Ishibashi H, Maruyama H, Takahashi M, Shimada T, Kamesaki H, Fujiwara K, Imazeki F, Yokosuka O. Demonstration of intrahepatic accumulated microbubble on ultrasound represents the grade of hepatic fibrosis. Eur Radiol. 2012 May;22(5):1083-90.

  13. Oonishi K, Cui X, Hirakawa H, Fujimori A, Kamijo T, Yamada S, Yokosuka O, Kamada T. Different effects of carbon ion beams and X-rays on clonogenic survival and DNA repair in human pancreatic cancer stem-like cells. Radiother Oncol. 2012 Nov;105(2):258-65.

  14. Matsumura T, Arai M, Sato T, Nakagawa T, Maruoka D, Tsuboi M, Hata S, Arai E, Katsuno T, Imazeki F, Yokosuka O. Efficacy of computed image modification of capsule endoscopy in patients with obscure gastrointestinal bleeding. World J Gastrointest Endosc. 2012 Sep 16;4(9):421-8.

  15. Kanda T, Shinozaki M, Kamezaki H, Wu S, Nakamoto S, Arai M, Fujiwara K, Goto N, Imazeki F, Yokosuka O. Efficacy of lamivudine or entecavir on acute exacerbation of chronic hepatitis B. Int J Med Sci. 2012;9(1):27-32.

  16. Maruyama H, Takahashi M, Shimada T, Yokosuka O. Emergency anticoagulation treatment for cirrhosis patients with portal vein thrombosis and acute variceal bleeding. Scand J Gastroenterol. 2012 Jun;47(6):686-91.

  17. Sazuka S, Takahashi Y, Kawaguchi T, Sato T, Nakagawa T, Furuya Y, Saito M, Saito K, Katsuno T, Nakaseko C, Yokosuka O. Endoscopic findings of small-intestinal Epstein-Barr virus-associated T-cell lymphoproliferative disorder. Endoscopy. 2012;44 Suppl 2 UCTN:E30-1.

  18. Sakai Y, Tsuyuguchi T, Sugiyama H, Nishikawa T, Kurosawa J, Saito M, Tawada K, Mikata R, Tada M, Ishihara T, Yokosuka O. Endoscopic Sphincterotomy Combined with Large Balloon Dilation for Removal of Large Bile Duct Stones. Hepatogastroenterology. 2012 May 29;60(121).

  19. Matsuyama M, Kondo F, Ishihara T, Yamaguchi T, Ito R, Tsuyuguchi T, Tawada K, Yokosuka O. Evaluation of pancreatic intraepithelial neoplasia and mucin expression in normal pancreata. J Hepatobiliary Pancreat Sci. 2012 May;19(3):242-8.

  20. Sato T, Miyawaki T, Katsuno T, Nakagawa T, Inoue M, Watanabe Y, Hishikawa E, Arai M, Yokosuka O. Flicking method: a novel colonoscope insertion method for surveillance colonoscopy in ulcerative colitis patients. Dig Endosc. 2012 Sep;24(5):343-7.

  21. Fujiwara K, Yokosuka O. Frequent detection of immunoglobulin M anti-herpes simplex viral antibody in patients with primary biliary cirrhosis. Hepatology. 2012 Jul;56(1):395.

  22. Kaneko S, Furuse J, Kudo M, Ikeda K, Honda M, Nakamoto Y, Onchi M, Shiota G, Yokosuka O, Sakaida I, Takehara T, Ueno Y, Hiroishi K, Nishiguchi S, Moriwaki H, Yamamoto K, Sata M, Obi S, Miyayama S, Imai Y. Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update. Hepatol Res. 2012 Jun;42(6):523-542.

  23. Inoue M, Chiba T, Zen Y, Yokota H, Kanda T, Ogasawara S, Sugiyama H, Arai M, Kanai F, Ogawa M, Imazeki F, Yokosuka O. Hepatic sarcoidosis with an increased serum level of immunoglobulin G4. Intern Med. 2012;51(21):3095-8.

  24. Tominaga A, Kanda T, Akiike T, Komoda H, Ito K, Abe A, Aruga A, Kaneda S, Saito M, Kiyohara T, Wakita T, Ishii K, Yokosuka O, Sugiura N. Hepatitis A outbreak associated with a revolving sushi bar in Chiba, Japan: Application of molecular epidemiology. Hepatol Res. 2012 Aug;42(8):828-34.

  25. Yan J, Kanda T, Wu S, Imazeki F, Yokosuka O. Hepatitis A, B, C and E virus markers in Chinese residing in Tokyo, Japan. Hepatol Res. 2012 Oct;42(10):974-81.

  26. Wu S, Kanda T, Imazeki F, Nakamoto S, Tanaka T, Arai M, Roger T, Shirasawa H, Nomura F, Yokosuka O. Hepatitis B virus e antigen physically associates with receptor-interacting serine/threonine protein kinase 2 and regulates IL-6 gene expression. J Infect Dis. 2012 Aug 1;206(3):415-20.

  27. Maruyama H, Takahashi M, Sekimoto T, Kamesaki H, Shimada T, Kanai F, Yokosuka O. Heterogeneity of microbubble accumulation: a novel approach to discriminate between well-differentiated hepatocellular carcinomas and regenerative nodules. Ultrasound Med Biol. 2012 Mar;38(3):383-8.

  28. Shimada T, Maruyama H, Sekimoto T, Kamezaki H, Takahashi M, Yokosuka O. Heterogeneous staining in the liver parenchyma after the injection of perflubutane microbubble contrast agent. Ultrasound Med Biol. 2012 Aug;38(8):1317-23.

  29. Maruyama K, Yokoyama A, Matsui T, Mizukami T, Mizukami Y, Sogawa K, Yokosuka O, Nomura F, Yokoyama T. Higher serum free glycerol levels in a group of alcoholics than in controls. Alcohol Clin Exp Res. 2012 Oct;36(10):1820-6..

  30. Fujiwara K, Yokosuka O. Histological discrimination between autoimmune hepatitis and drug-induced liver injury. Hepatology. 2012 Feb;55(2):657.

  31. Kikkawa S, Sogawa K, Satoh M, Umemura H, Kodera Y, Matsushita K, Tomonaga T, Miyazaki M, Yokosuka O, Nomura F. Identification of a Novel Biomarker for Biliary Tract Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry. Int J Proteomics. 2012;2012:108609.

  32. Yasui S, Fujiwara K, Okitsu K, Yonemitsu Y, Ito H, Yokosuka O. Importance of computed tomography imaging features for the diagnosis of autoimmune acute liver failure. Hepatol Res. 2012 Jan;42(1):42-50.

  33. Tanaka T, Sugaya S, Kita K, Arai M, Kanda T, Fujii K, Imazeki F, Sugita K, Yokosuka O, Suzuki N. Inhibition of cell viability by human IFN-β is mediated by microRNA-431. Int J Oncol. 2012 May;40(5):1470-6.

  34. Kanda T, Wu S, Kiyohara T, Nakamoto S, Jiang X, Miyamura T, Imazeki F, Ishii K, Wakita T, Yokosuka O. Interleukin-29 suppresses hepatitis A and C viral internal ribosomal entry site-mediated translation. Viral Immunol. 2012 Oct;25(5):379-86.

  35. Saito M, Katsuno T, Nakagawa T, Sato T, Noguchi Y, Sazuka S, Saito K, Arai M, Yokote K, Yokosuka O. Intestinal epithelial cells with impaired autophagy lose their adhesive capacity in the presence of TNF-α. Dig Dis Sci. 2012 Aug;57(8):2022-30.

  36. Wu S, Kanda T, Nakamoto S, Imazeki F, Yokosuka O. Knockdown of receptor-interacting serine/threonine protein kinase-2 (RIPK2) affects EMT-associated gene expression in human hepatoma cells. Anticancer Res. 2012 Sep;32(9):3775-83.

  37. Takahashi M, Maruyama H, Shimada T, Kamezaki H, Okabe S, Kanai F, Yoshikawa M, Yokosuka O. Linear enhancement after radio-frequency ablation for hepatocellular carcinoma: is it a sign of recurrence? Ultrasound Med Biol. 2012 Nov;38(11):1902-10.

  38. Maruoka D, Imazeki F, Arai M, Kanda T, Fujiwara K, Yokosuka O. Longitudinal changes of the laboratory data of chronic hepatitis C patients with sustained virological response on long-term follow-up. J Viral Hepat. 2012 Feb;19(2):e97-104.

  39. Maruoka D, Imazeki F, Arai M, Kanda T, Fujiwara K, Yokosuka O. Long-term cohort study of chronic hepatitis C according to interferon efficacy. J Gastroenterol Hepatol. 2012 Feb;27(2):291-9.

  40. Maruyama H, Okugawa H, Kobayashi S, Yoshizumi H, Takahashi M, Ishibashi H, Yokosuka O. Non-invasive portography: a microbubble-induced three-dimensional sonogram for discriminating idiopathic portal hypertension from cirrhosis. Br J Radiol. 2012 May;85(1013):587-95.

  41. Maruyama H, Yokosuka O. Pathophysiology of portal hypertension and esophageal varices. Int J Hepatol. 2012;2012:895787.

  42. Miyamura T, Ishii K, Kanda T, Tawada A, Sekimoto T, Wu S, Nakamoto S, Arai M, Fujiwara K, Imazeki F, Kiyohara T, Wakita T, Yokosuka O. Possible widespread presence of hepatitis A virus subgenotype IIIA in Japan: Recent trend of hepatitis A causing acute liver failure. Hepatol Res. 2012 Mar;42(3):248-53.

  43. Sugiyama H, Tsuyuguchi T, Sakai Y, Ohtsuka M, Miyazaki M, Yokosuka O. Potential role of peroral cholangioscopy for preoperative diagnosis of cholangiocarcinoma. Surg Laparosc Endosc Percutan Tech. 2012 Dec;22(6):532-6.

  44. Maruyama H, Ishibashi H, Takahashi M, Shimada T, Kamesaki H, Yokosuka O. Prediction of the therapeutic effects of anticoagulation for recent portal vein thrombosis: a novel approach with contrast-enhanced ultrasound. Abdom Imaging. 2012 Jun;37(3):431-8.

  45. Saito K, Katsuno T, Nakagawa T, Saito M, Sazuka S, Sato T, Matsumura T, Arai M, Miyauchi H, Matsubara H, Yokosuka O. Predictive factors of response to intravenous ciclosporin in severe ulcerative colitis: the development of a novel prediction formula. Aliment Pharmacol Ther. 2012 Oct;36(8):744-54.

  46. Sugiyama H, Tsuyuguchi T, Sakai Y, Nisikawa T, Miyazaki M, Yokosuka O. Preoperative Drainage for Distal Biliary Obstruction: Endoscopic Stenting or Nasobiliary Drainage? Hepatogastroenterology. 2012 Sep 14;60(122).

  47. Murayama A, Kato T, Akazawa D, Sugiyama N, Date T, Masaki T, Nakamoto S, Tanaka Y, Mizokami M, Yokosuka O, Nomoto A, Wakita T. Production of infectious chimeric hepatitis C virus genotype 2b harboring minimal regions of JFH-1. J Virol. 2012 Feb;86(4):2143-52.

  48. Tsuyuguchi T, Sugiyama H, Sakai Y, Nishikawa T, Yokosuka O, Mayumi T, Kiriyama S, Yokoe M, Takada T. Prognostic factors of acute cholangitis in cases managed using the Tokyo Guidelines. J Hepatobiliary Pancreat Sci. 2012 Sep;19(5):557-65.

  49. Arai M, Togo S, Kanda T, Fujiwara K, Imazeki F, Yokosuka O. Quantification of hepatitis B surface antigen can help predict spontaneous hepatitis B surface antigen seroclearance. Eur J Gastroenterol Hepatol. 2012 Apr;24(4):414-8.

  50. Ueda T, Tsuchiya K, Hashimoto S, Inoue T, Enomoto N, Inao M, Tanaka A, Kaito M, Imazeki F, Nishiguchi S, Mochida S, Yokosuka O, Yatsuhashi H, Izumi N, Kudo M; RETRY Study Group. Retreatment with peginterferon α-2a + ribavirin in patients who failed previous peginterferon α-2b + ribavirin combination therapy. Dig Dis. 2012;30(6):554-60.

  51. Arai M, Matsumura T, Tsuchiya N, Sadakane C, Inami R, Suzuki T, Yoshikawa M, Imazeki F, Yokosuka O. Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin. Hepatogastroenterology. 2012 Jan-Feb;59(113):62-6.

  52. Miyamura T, Kanda T, Nakamoto S, Wu S, Jiang X, Arai M, Fujiwara K, Imazeki F, Yokosuka O. Roles of ITPA and IL28B genotypes in chronic hepatitis C patients treated with peginterferon plus ribavirin. Viruses. 2012 Aug;4(8):1264-78.

  53. Nomura F, Sogawa K, Noda K, Seimiya M, Matsushita K, Miura T, Tomonaga T, Yoshitomi H, Imazeki F, Takizawa H, Mogushi K, Miyazaki M, Yokosuka O. Serum anti-Ku86 is a potential biomarker for early detection of hepatitis C virus-related hepatocellular carcinoma. Biochem Biophys Res Commun. 2012 May 18;421(4):837-43.

  54. Arai E, Arai M, Uchiyama T, Higuchi Y, Aoyagi K, Yamanaka Y, Yamamoto T, Nagano O, Shiina A, Maruoka D, Matsumura T, Nakagawa T, Katsuno T, Imazeki F, Saeki N, Kuwabara S, Yokosuka O. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease. Brain. 2012 May;135(Pt 5):1478-85.

  55. Kimura A, Sogawa K, Satoh M, Kodera Y, Yokosuka O, Tomonaga T, Nomura F. The application of a three-step serum proteome analysis for the discovery and identification of novel biomarkers of hepatocellular carcinoma. Int J Proteomics. 2012;2012:623190.

  56. Narahara Y, Kanazawa H, Sakamoto C, Maruyama H, Yokosuka O, Mochida S, Uemura M, Fukui H, Sumino Y, Matsuzaki Y, Masaki N, Kokubu S, Okita K. The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study. J Gastroenterol. 2012 Mar;47(3):313-20.

  57. Kanaya T, Hase K, Takahashi D, Fukuda S, Hoshino K, Sasaki I, Hemmi H, Knoop KA, Kumar N, Sato M, Katsuno T, Yokosuka O, Toyooka K, Nakai K, Sakamoto A, Kitahara Y, Jinnohara T, McSorley SJ, Kaisho T, Williams IR, Ohno H. The Ets transcription factor Spi-B is essential for the differentiation of intestinal microfold cells. Nat Immunol. 2012 Jun 17;13(8):729-36.

2011年

  1. Arai M, Matsumura T, Yoshikawa M, Imazeki F, Yokosuka O. [Analysis of the Rikkunshito efficacy on patients with functional dyspepsia]. Nihon Yakurigaku Zasshi. 2011 Jan;137(1):18-21.

  2. Imazeki F, Wu S, Arai M, Kanda T, Yokosuka O. [HBeAg and HBV DNA in chronic hepatitis B]. Nihon Rinsho. 2011 May;69 Suppl 4:428-33.

  3. Yokosuka O, Arai M. [The factors associated with pathology, treatment and prognosis of chronic hepatitis B]. Nihon Rinsho. 2011 May;69 Suppl 4:462-8.

  4. Seza K, Yamaguchi T, Ishihara T, Tadenema H, Tawada K, Saisho H, Yokosuka O. A long-term controlled trial of endoscopic pancreatic stenting for treatment of main pancreatic duct stricture in chronic pancreatitis. Hepatogastroenterology. 2011 Nov-Dec;58(112):2128-31.

  5. Fujiwara K, Nakano M, Yasui S, Okitsu K, Yonemitsu Y, Yokosuka O. Advancedhistology and impaired liver regeneration are associated with disease severity in acute-onset autoimmune hepatitis. Histopathology. 2011 Apr;58(5):693-704.

  6. Hamano Y, Okude T, Yokosuka O, Ogawa M. Attenuation of Immune-Mediated Renal Injury by Telmisartan, an Angiotensin Receptor Blocker and a Selective PPAR-γ Activator. Nephron Extra. 2011 Jan;1(1):78-90.

  7. Yasui S, Fujiwara K, Yokosuka O. Autoimmune fulminant hepatic failure in chronic hepatitis C during Peg-interferon-alpha 2b plus ribavirin treatment showing histological heterogeneity. ig Liver Dis. 2011 Aug;43(8):666-7.

  8. Fujiwara K, Yasui S, Tawada A, Okitsu K, Yonemitsu Y, Chiba T, Arai M, Kanda T, Imazeki F, Nakano M, Oda S, Yokosuka O. Autoimmune fulminant liver failure in adults: Experience in a Japanese center. Hepatol Res. 2011 Feb;41(2):133-41.

  9. Togo S, Arai M, Tawada A, Chiba T, Kanda T, Fujiwara K, Imazeki F, Yokosuka O. Clinical importance of serum hepatitis B surface antigen levels in chronic hepatitis B. J Viral Hepat. 2011 Oct;18(10):e508-15.

  10. Yasui S, Fujiwara K, Yonemitsu Y, Oda S, Nakano M, Yokosuka O. Clinicopathological features of severe and fulminant forms of autoimmune hepatitis. J Gastroenterol. 2011 Mar;46(3):378-90.

  11. Takahashi M, Maruyama H, Ishibashi H, Yoshikawa M, Yokosuka O. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma. AJR Am J Roentgenol. 2011 Feb;196(2):W123-31.

  12. Nishimura M, Yamamoto H, Yoshida T, Seimiya M, Sawabe Y, Matsushita K, Umemura H, Sogawa K, Takizawa H, Yokosuka O, Nomura F. Decreases in the serum VLDL-TG/non-VLDL-TG ratio from early stages of chronic hepatitis C: alterations in TG-rich lipoprotein levels. PLoS One. 2011 Feb 25;6(2):e17309.

  13. Okamoto Y, Masaki T, Murayama A, Munakata T, Nomoto A, Nakamoto S, Yokosuka O, Watanabe H, Wakita T, Kato T. Development of recombinant hepatitis C virus with NS5A from strains of genotypes 1 and 2. Biochem Biophys Res Commun. 2011 Jul 8;410(3):404-9.

  14. Fujiwara K, Yasui S, Tawada A, Fukuda Y, Nakano M, Yokosuka O. Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group criteria in acute-onset autoimmune hepatitis. Liver Int. 2011 Aug;31(7):1013-20.

  15. Ambiru S, Nakamura S, Mandai Y, Sato T, Kuwahara T, Yokosuka O. Ectopic ileal varices associated with recurrent bleeding: report of a case. Surg Today. 2011 Mar;41(3):448-52.

  16. Fujiwara K, Yasui S, Yokosuka O. Efforts at making the diagnosis of acute-onset autoimmune hepatitis. Hepatology. 2011 Jul;54(1):371-2; author reply 373.

  17. Kamezaki H, Kanda T, Wu S, Nakamoto S, Arai M, Maruyama H, Fujiwara K, Imazeki F, Yokosuka O. Emergence of entecavir-resistant mutations in nucleos(t)ide-naive Japanese patients infected with hepatitis B virus: virological breakthrough is also dependent on adherence to medication. Scand J Gastroenterol. 2011 Sep;46(9):1111-7.

  18. Tanaka T, Arai M, Wu S, Kanda T, Miyauchi H, Imazeki F, Matsubara H, Yokosuka O. Epigenetic silencing of microRNA-373 plays an important role in regulating cell liferation in colon cancer. Oncol Rep. 2011 Nov;26(5):1329-35.

  19. Wu S, Imazeki F, Kurbanov F, Fukai K, Arai M, Kanda T, Yonemitsu Y, Tanaka Y, Mizokami M, Yokosuka O. Evolution of hepatitis B genotype C viral quasi-species during hepatitis B e antigen seroconversion. J Hepatol. 2011 Jan;54(1):19-25.

  20. Suzuki T, Arai M, Matsumura T, Arai E, Hata S, Maruoka D, Tanaka T, Nakamoto S, Imazeki F, Yokosuka O. Factors Associated with Inadequate Tissue Yield in EUS-FNA for Gastric SMT. ISRN Gastroenterol. 2011;2011:619128.

  21. Yasui S, Fujiwara K, Tawada A, Fukuda Y, Nakano M, Yokosuka O. fficacy of intravenous glycyrrhizin in the early stage of acute onset autoimmune hepatitis. Dig Dis Sci. 2011 Dec;56(12):3638-47.

  22. Miyamura T, Kanda T, Nakamoto S, Wu S, Fujiwara K, Imazeki F, Yokosuka O. Hepatic STAT1-nuclear translocation and interleukin 28B polymorphisms predict treatment outcomes in hepatitis C virus genotype 1-infected patients. PLoS One. 2011;6(12):e28617.

  23. Fujiwara K, Kojima H, Yasui S, Okitsu K, Yonemitsu Y, Omata M, Yokosuka O. Hepatitis A viral load in relation to severity of the infection. J Med Virol. 2011 Feb;83(2):201-7

  24. Tamura R, Kanda T, Imazeki F, Wu S, Nakamoto S, Tanaka T, Arai M, Fujiwara K, Saito K, Roger T, Wakita T, Shirasawa H, Yokosuka O. Hepatitis C Virus nonstructural 5A protein inhibits lipopolysaccharide-mediated apoptosis of hepatocytes by decreasing expression of Toll-like receptor 4. J Infect Dis. 2011 Sep 1;204(5):793-801.

  25. Watanabe S, Kishimoto T, Yokosuka O. Hepatocyte growth factor inhibits anoikis of pancreatic carcinoma cells through phosphatidylinositol 3-kinase pathway. Pancreas. 2011 May;40(4):608-14.

  26. Sogawa K, Kodera Y, Satoh M, Kawashima Y, Umemura H, Maruyama K, Takizawa H, Yokosuka O, Nomura F. Increased serum levels of pigment epithelium-derived factor by excessive alcohol consumption-detection and identification by a three-step serum proteome analysis. Alcohol Clin Exp Res. 2011 Feb;35(2):211-7.

  27. Wu S, Fukai K, Imazeki F, Arai M, Kanda T, Yonemitsu Y, Yokosuka O. Initial virological response and viral mutation with adefovir dipivoxil added to ongoing Lamivudine therapy in Lamivudine-resistant chronic hepatitis B. Dig Dis Sci. 2011 Apr;56(4):1207-14.

  28. Tsuyuguchi T, Sakai Y, Sugiyama H, Ishihara T, Yokosuka O. Long-term follow-up after peroral cholangioscopy-directed lithotripsy in patients with difficult bile duct stones, including Mirizzi syndrome: an analysis of risk factors predicting stone recurrence. Surg Endosc. 2011 Jul;25(7):2179-85.

  29. Bekku D, Arai M, Imazeki F, Yonemitsu Y, Kanda T, Fujiwara K, Fukai K, Sato K, Itoga S, Nomura F, Yokosuka O. Long-term follow-up of patients with hepatitis B e antigen negative chronic hepatitis B. J Gastroenterol Hepatol. 2011 Jan;26(1):122-8.

  30. Yokosuka O, Kurosaki M, Imazeki F, Arase Y, Tanaka Y, Chayama K, Tanaka E, Kumada H, Izumi N, Mizokami M, Kudo M. Management of hepatitis B: Consensus of the Japan Society of Hepatology 2009. Hepatol Res. 2011 Jan;41(1):1-21.

  31. Ueno H, Okusaka T, Furuse J, Yamao K, Funakoshi A, Boku N, Ohkawa S, Yokosuka O, Tanaka K, Moriyasu F, Nakamori S, Sato T. Multicenter phase II study of gemcitabine and S-1 combination therapy (GS Therapy) in patients with metastatic pancreatic cancer. Jpn J Clin Oncol. 2011 Aug;41(8):953-8.

  32. Matsumura T, Arai M, Sazuka S, Saito M, Takahashi Y, Maruoka D, Suzuki T, Nakagawa T, Sato T, Katsuno T, Imazeki F, Yokosuka O. Negative capsule endoscopy for obscure gastrointestinal bleeding is closely associated with the use of low-dose aspirin. Scand J Gastroenterol. 2011 May;46(5):621-6.

  33. Sakai Y, Ishihara T, Tsuyuguchi T, Tawada K, Saito M, Kurosawa J, Tamura R, Togo S, Mikata R, Tada M, Yokosuka O. New cannulation method for pancreatic duct cannulation-bile duct guidewire-indwelling method. World J Gastrointest Endosc. 2011 Nov 16;3(11):231-4.

  34. Wu S, Kanda T, Imazeki F, Nakamoto S, Shirasawa H, Yokosuka O. Nuclear receptor mRNA expression by HBV in human hepatoblastoma cell lines. Cancer Lett. 2011 Dec 15;312(1):33-42.

  35. Kanda T, Imazeki F, Mikami S, Kato K, Shimada N, Yonemitsu Y, Miyauchi T, Arai M, Fujiwara K, Tsubota A, Takada N, Nishino T, Takashi M, Sugiura N, Kimura M, Fukai K, Yokosuka O. Occurrence of hepatocellular carcinoma was not a rare event during and immediately after antiviral treatment in Japanese HCV-positive patients. Oncology. 2011;80(5-6):366-72.

  36. Sakai Y, Tsuyuguchi T, Mikata R, Sugiyama H, Yasui S, Eto R, Fujimoto T, Tamura R, Togo S, Tada M, Ishihara T, Yokosuka O. Pancreatic duct guidewire-indwelling method for patients resistant to selective biliary cannulation and usefulness of pre-cut papillotomy following unsuccessful biliary cannulation with pancreatic duct guidewire-indwelling method. Hepatogastroenterology. 2011 May-Jun;58(107-108):698-704.

  37. Kanda T, Yokosuka O. Pegylated interferon-alfa plus ribavirin therapies for chronic hepatitis C. JNMA J Nepal Med Assoc. 2011 Jan-Mar;51(181):41-8.

  38. Sudo K, Yamaguchi T, Ishihara T, Nakamura K, Hara T, Denda T, Tawada K, Imagumbai T, Araki H, Sakai M, Hatano K, Kawakami H, Uno T, Ito H, Yokosuka O. Phase II study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):119-25.

  39. Sudo K, Yamaguchi T, Nakamura K, Denda T, Hara T, Ishihara T, Yokosuka O. Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer. Cancer Chemother Pharmacol. 2011 Feb;67(2):249-54.

  40. Origasa H, Goto S, Shimada K, Uchiyama S, Okada Y, Sugano K, Hiraishi H, Uemura N, Ikeda Y; MAGIC Investigators. Prospective cohort study of gastrointestinal complications and vascular diseases in patients taking aspirin: rationale and design of the MAGIC Study. Cardiovasc Drugs Ther. 2011 Dec;25(6):551-60.

  41. Kanda T, Imazeki F, Yonemitsu Y, Mikami S, Takada N, Nishino T, Takashi M, Tsubota A, Kato K, Sugiura N, Tawada A, Wu S, Tanaka T, Nakamoto S, Mikata R, Tada M, Chiba T, Kurihara T, Arai M, Fujiwara K, Kanai F, Yokosuka O. Quantification of hepatitis C virus in patients treated with peginterferon-alfa 2a plus ribavirin treatment by COBAS TaqMan HCV test. J Viral Hepat. 2011 Jul;18(7):e292-7.

  42. Kanda T, Imazeki F, Azemoto R, Yonemitsu Y, Mikami S, Kita K, Takashi M, Sunaga M, Wu S, Nakamoto S, Tawada A, Arai M, Kato K, Yoshida Y, Koma Y, Fujiwara K, Fukai K, Suzuki N, Yokosuka O. Response to peginterferon-alfa 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 2. Dig Dis Sci. 2011 Nov;56(11):3335-42.

  43. Ogasawara S, Kanai F, Obi S, Sato S, Yamaguchi T, Azemoto R, Mizumoto H, Koushima Y, Morimoto N, Hirata N, Toriyabe T, Shinozaki Y, Ooka Y, Mikata R, Chiba T, Okabe S, Imazeki F, Yoshikawa M, Yokosuka O. Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma. Hepatol Int. 2011 Sep;5(3):850-6.

  44. Nakamoto S, Kanda T, Imazeki F, Wu S, Arai M, Fujiwara K, Yokosuka O. Simple assay based on restriction fragment length polymorphism associated with IL28B in chronic hepatitis C patients. Scand J Gastroenterol. 2011 Jul;46(7-8):955-61.

  45. Furukawa K, Sato T, Katsuno T, Nakagawa T, Noguchi Y, Tokumasa A, Yokote K, Yokosuka O, Saito Y. Smad3 contributes to positioning of proliferating cells in colonic crypts by inducing EphB receptor protein expression. Biochem Biophys Res Commun. 2011 Feb 25;405(4):521-6.

  46. Kanda T, Imazeki F, Wu S, Nakamoto S, Yokosuka O. The assessment of serum hepatitis C virus RNA 12 weeks after the end of treatment using TaqMan polymerase chain reaction is less relevant than after 24 weeks for predicting sustained virological response. Hepatology. 2011 Oct;54(4):1482; author reply 1482-3.

  47. Takahashi D, Hase K, Kimura S, Nakatsu F, Ohmae M, Mandai Y, Sato T, Date Y, Ebisawa M, Kato T, Obata Y, Fukuda S, Kawamura YI, Dohi T, Katsuno T, Yokosuka O, Waguri S, Ohno H. The epithelia-specific membrane trafficking factor AP-1B controls gut immune homeostasis in mice. Gastroenterology. 2011 Aug;141(2):621-32.

  48. Sogawa K, Kodera Y, Noda K, Ishizuka Y, Yamada M, Umemura H, Maruyama K, Tomonaga T, Yokosuka O, Nomura F. The measurement of a fibrinogen α C-chain 5.9 kDa fragment (FIC 5.9) using MALDI-TOF MS and a stable isotope-labeled peptide standard dilution. Clin Chim Acta. 2011 May 12;412(11-12):1094-9.

  49. Sakai Y, Tsuyuguchi T, Sugiyama H, Kurosawa J, Saito M, Tawada K, Mikata R, Tada M, Ishihara T, Yokosuka O. Transpancreatic precut papillotomy in patients with difficulty in selective biliary cannulation. Hepatogastroenterology. 2011 Nov-Dec;58(112):1853-8.

  50. Sakai Y, Tsuyuguchi T, Mikata R, Tawada K, Tada M, Togo S, Tamura R, Saito M, Kurosawa J, Ishihara T, Yokosuka O. Utility of placement of pancreatic duct spontaneous dislodgement stent for prevention of post-ERCP pancreatitis in patients with difficulty in selective biliary cannulation. Hepatogastroenterology. 2011 May-Jun;58(107-108):687-93.

2010年

  1. Kanai F, Omata M, Yokosuka O. [Current status and future perspective of molecular targeted therapy for hepatocellular carcinoma]. Nihon Shokakibyo Gakkai Zasshi. 2009 Dec;106(12):1727-35.

  2. Mimura N, Tsujimura H, Ise M, Sakai C, Kojima H, Fukai K, Yokosuka O, Takagi T, Kumagai K. [Hepatitis B virus reactivation after cessation of prophylactic lamivudine therapy in B-cell lymphoma patients treated with rituximab combined CHOP therapy]. Rinsho Ketsueki. 2009 Dec;50(12):1715-9.

  3. Sakai Y, Tsuyuguchi T, Ishihara T, Sugiyama H, Eto R, Fujimoto T, Yasui S, Tamura R, Togo S, Tada M, Yokosuka O. Cholangiopancreatography troubleshooting: the usefulness of endoscopic retrieval of migrated biliary and pancreatic stents. Hepatobiliary Pancreat Dis Int. 2009 Dec;8(6):632-7.

  4. Sakai Y, Ishihara T, Tsuyuguchi T, Nakamoto S, Miyakawa K, Sugiyama H, Yasui S, Fujimoto T, Eto R, Miyazaki M, Yokosuka O. Clinical evaluation of endosonography-guided biliary drainage for patients with the difficulty with placing of internal drainage. Hepatogastroenterology. 2009 Nov-Dec;56(96):1596-9.

  5. Nakamoto S, Sakai Y, Kasanuki J, Kondo F, Ooka Y, Kato K, Arai M, Suzuki T, Matsumura T, Bekku D, Ito K, Tanaka T, Yokosuka O. Indications for the use of endoscopic mucosal resection for early gastric cancer in Japan: a comparative study with endoscopic submucosal dissection. Endoscopy. 2009 Sep;41(9):746-50.

  6. Nagao Y, Matsuoka H, Seike M, Yamasaki K, Kato J, Nakajima T, Miyazaki Y, Ohno T, Inuzuka S, Ohira H, Yokosuka O, Yatsuhashi H, Mori T, Honda K, Kawaguchi T, Ide T, Sata M. Knowledge of Vibrio vulnificus infection among Japanese patients with liver diseases: a prospective multicenter study. Med Sci Monit. 2009 Oct;15(10):PH115-120.

  7. Sakai Y, Tsuyuguchi T, Ishihara T, Yukisawa S, Sugiyama H, Miyakawa K, Kuroda Y, Yamaguchi T, Ozawa S, Yokosuka O. Long-term prognosis of patients with endoscopically treated postoperative bile duct stricture and bile duct stricture due to chronic pancreatitis. J Gastroenterol Hepatol. 2009 Jul;24(7):1191-7.

  8. Fujimoto T, Tomizawa M, Yokosuka O. SiRNA of frizzled-9 suppresses proliferation and motility of hepatoma cells. Int J Oncol. 2009 Oct;35(4):861-6

  9. Sakai Y, Tsuyuguchi T, Ishihara T, Sugiyama H, Miyakawa K, Yasui S, Eto R, Fujimoto T, Shimizu H, Miyazaki M, Yokosuka O. The successful use of peroral cholangioscopy for the diagnosis and treatment of the biliary tract lesions and giant bile duct stones in a 76-year-old man. Surg Laparosc Endosc Percutan Tech. 2009 Dec;19(6):e237-40.

  10. Sakai Y, Tsuyuguchi T, Ishihara T, Sugiyama H, Miyakawa K, Yukisawa S, Yasui S, Eto R, Fujimoto T, Kaiho T, Miyazaki M, Yokosuka O. The usefulness of endoscopic transpapillary procedure in post-cholecystectomy bile duct stricture and post-cholecystectomy bile leakage. Hepatogastroenterology. 2009 Jul-Aug;56(93):978-83.

  11. Tomizawa M, Tsuyuguchi T, Sakai Y, Sugiyama H, Miyakawa K, Ishihara T, Yokosuka O. [Case of intrahepatic cholangiocarcinoma drained through a fistula of the duodenal bulb]. Nihon Shokakibyo Gakkai Zasshi. 2010 Dec;107(12):1970-7.

  12. Mimura N, Kojima H, Tsujimura H, Ise M, Sakai C, Fukai K, Yokosuka O, Kumagai K. [Prevention of hepatitis B virus reactivation in B-cell lymphoma patients receiving chemotherapy with rituximab]. Rinsho Ketsueki. 2010 Mar;51(3):213-5.

  13. Fujiwara K, Yokosuka O. [Serum anti-hepatitis A virus antibody and hepatitis A virus RNA]. Nihon Rinsho. 2010 Jun;68 Suppl 6:435-8.

  14. Takeda S, Sato T, Katsuno T, Nakagawa T, Noguchi Y, Yokosuka O, Saito Y. Adsorptive depletion of alpha4 integrin(hi)- and CX3CR1hi-expressing proinflammatory monocytes in patients with ulcerative colitis. Dig Dis Sci. 2010 Jul;55(7):1886-95.

  15. Kanda T, Jeong SH, Imazeki F, Fujiwara K, Yokosuka O. Analysis of 5' nontranslated region of hepatitis A viral RNA genotype I from South Korea: comparison with disease severities. PLoS One. 2010 Dec 28;5(12):e15139.

  16. Ishibashi H, Maruyama H, Takahashi M, Fujiwara K, Imazeki F, Yokosuka O. Assessment of hepatic fibrosis by analysis of the dynamic behaviour of microbubbles during contrast ultrasonography. Liver Int. 2010 Oct;30(9):1355-63.

  17. Nakamoto S, Imazeki F, Fukai K, Fujiwara K, Arai M, Kanda T, Yonemitsu Y, Yokosuka O. Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development. J Hepatol. 2010 Jan;52(1):72-8.

  18. Mikata R, Fukai K, Imazeki F, Arai M, Fujiwara K, Yonemitsu Y, Zhang K, Nabeya Y, Ochiai T, Yokosuka O. BCL2L10 is frequently silenced by promoter hypermethylation in gastric cancer. Oncol Rep. 2010 Jun;23(6):1701-8.

  19. Chiba T, Seki A, Aoki R, Ichikawa H, Negishi M, Miyagi S, Oguro H, Saraya A, Kamiya A, Nakauchi H, Yokosuka O, Iwama A. Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf-dependent and -independent manners in mice. Hepatology. 2010 Sep;52(3):1111-23.

  20. Maruyama H, Okugawa H, Ishibashi H, Takahashi M, Kobayashi S, Yoshizumi H, Yokosuka O. Carbon dioxide-based portography: an alternative to conventional imaging with the use of iodinated contrast medium. J Gastroenterol Hepatol. 2010 Jun;25(6):1111-6.

  21. Maruyama H, Takahashi M, Ishibashi H, Okabe S, Yoshikawa M, Yokosuka O. Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma. Eur J Radiol. 2010 Jul;75(1):e102-6.

  22. Imada H, Kato H, Yasuda S, Yamada S, Yanagi T, Kishimoto R, Kandatsu S, Mizoe JE, Kamada T, Yokosuka O, Tsujii H. Comparison of efficacy and toxicity of short-course carbon ion radiotherapy for hepatocellular carcinoma depending on their proximity to the porta hepatis. Radiother Oncol. 2010 Aug;96(2):231-5.

  23. Imada H, Kato H, Yasuda S, Yamada S, Yanagi T, Hara R, Kishimoto R, Kandatsu S, Minohara S, Mizoe JE, Kamada T, Yokosuka O, Tsujii H. Compensatory enlargement of the liver after treatment of hepatocellular carcinoma with carbon ion radiotherapy - relation to prognosis and liver function. Radiother Oncol. 2010 Aug;96(2):236-42.

  24. Tsuyuguchi T, Sakai Y, Sugiyama H, Miyakawa K, Ishihara T, Ohtsuka M, Miyazaki M, Yokosuka O Endoscopic diagnosis of intraductal papillary mucinous neoplasm of the bile duct. J Hepatobiliary Pancreat Sci. 2010 May;17(3):230-5.

  25. Sugawara T, Oguro H, Negishi M, Morita Y, Ichikawa H, Iseki T, Yokosuka O, Nakauchi H, Iwama A. FET family proto-oncogene Fus contributes to self-renewal of hematopoietic stem cells. Exp Hematol. 2010 Aug;38(8):696-706.

  26. Kanda T, Gauss-Müller V, Cordes S, Tamura R, Okitsu K, Shuang W, Nakamoto S, Fujiwara K, Imazeki F, Yokosuka O. Hepatitis A virus (HAV) proteinase 3C inhibits HAV IRES-dependent translation and cleaves the polypyrimidine tract-binding protein. J Viral Hepat. 2010 Sep;17(9):618-23.

  27. Wu S, Kanda T, Imazeki F, Arai M, Yonemitsu Y, Nakamoto S, Fujiwara K, Fukai K, Nomura F, Yokosuka O. Hepatitis B virus e antigen downregulates cytokine production in human hepatoma cell lines. Viral Immunol. 2010 Oct;23(5):467-76.

  28. Imazeki F, Yokosuka O, Omata M. Impact of IL-28B SNPs on control of hepatitis C virus infection: a genome-wide association study. Expert Rev Anti Infect Ther. 2010 May;8(5):497-9.

  29. Takano S, Sogawa K, Yoshitomi H, Shida T, Mogushi K, Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Ishihara T, Tanaka H, Yokosuka O, Nomura F, Miyazaki M. Increased circulating cell signalling phosphoproteins in sera are useful for the detection of pancreatic cancer. Br J Cancer. 2010 Jul 13;103(2):223-31.

  30. Yang L, Kiyohara T, Kanda T, Imazeki F, Fujiwara K, Gauss-Müller V, Ishii K, Wakita T, Yokosuka O. Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha. Virol J. 2010 Sep 3;7:212.

  31. Kanda T, Imazeki F, Nakamoto S, Okitsu K, Fujiwara K, Yokosuka O. Internal ribosomal entry-site activities of clinical isolate-derived hepatitis A virus and inhibitory effects of amantadine. Hepatol Res. 2010 Apr 1;40(4):415-23.

  32. Okitsu K, Kanda T, Imazeki F, Yonemitsu Y, Ray RB, Chang C, Yokosuka O. Involvement of interleukin-6 and Androgen Receptor Signaling in Pancreatic Cancer. Genes Cancer. 2010 Aug;1(8):859-67.

  33. Hamano Y, Okude T, Shirai R, Sato I, Kimura R, Ogawa M, Ueda Y, Yokosuka O, Kalluri R, Ueda S. Lack of collagen XVIII/endostatin exacerbates immune-mediated glomerulonephritis. J Am Soc Nephrol. 2010 Sep;21(9):1445-55.

  34. Kuroda Y, Tsuyuguchi T, Sakai Y, K C S, Ishihara T, Yamaguchi T, Saisho H, Yokosuka O. Long-term follow-up evaluation for more than 10 years after endoscopic treatment for postoperative bile duct strictures. Surg Endosc. 2010 Apr;24(4):834-40.

  35. Fujimoto T, Tsuyuguchi T, Sakai Y, Sugiyama H, Miyakawa K, Eto R, Yasui S, Ishihara T, Yokosuka O. Long-term outcome of endoscopic papillotomy for choledocholithiasis with cholecystolithiasis. Dig Endosc. 2010 Apr;22(2):95-100.

  36. Yokosuka O, Takaguchi K, Fujioka S, Shindo M, Chayama K, Kobashi H, Hayashi N, Sato C, Kiyosawa K, Tanikawa K, Ishikawa H, Masaki N, Seriu T, Omata M. Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection. J Hepatol. 2010 Jun;52(6):791-9.

  37. Hamano Y, Aoki T, Shirai R, Hatano M, Kimura R, Ogawa M, Yokosuka O, Ueda S. Low-dose darbepoetin alpha attenuates progression of a mouse model of aristolochic acid nephropathy through early tubular protection. Nephron Exp Nephrol.. 2010;114(2):e69-81.

  38. Mukaide M, Tanaka Y, Shin-I T, Yuen MF, Kurbanov F, Yokosuka O, Sata M, Karino Y, Yamada G, Sakaguchi K, Orito E, Inoue M, Baqai S, Lai CL, Mizokami M. Mechanism of entecavir resistance of hepatitis B virus with viral breakthrough as determined by long-term clinical assessment and molecular docking simulation. Antimicrob Agents Chemother. 2010 Feb;54(2):882-9.

  39. Kanda T, Imazeki F, Yokosuka O. New antiviral therapies for chronic hepatitis C. Hepatol Int. 2010 Aug 19;4(3):548-61.

  40. Inoue M, Miyake Y, Odaka T, Sato T, Watanabe Y, Sakama A, Zenbutsu S, Yokosuk O. Objective evaluation of visibility in virtual chromoendoscopy for esophageal squamous carcinoma using a color difference formula. J Biomed Opt. 2010 Sep-Oct;15(5):056019.

  41. Kasuga A, Mizumoto H, Matsutani S, Kobayashi A, Endo T, Ando T, Yukisawa S, Maruyama H, Yokosuka O. Portal hemodynamics and clinical outcomes of patients with gastric varices after balloon-occluded retrograde transvenous obliteration. J Hepatobiliary Pancreat Sci. 2010 Nov;17(6):898-903.

  42. Maruyama H, Okugawa H, Kobayashi S, Yoshizumi H, Yokosuka O. Pre-treatment hemodynamic features involved with long-term survival of cirrhotic patients after embolization of gastric fundal varices. Eur J Radiol. 2010 Aug;75(2):e32-7.

  43. Tada M, Kanai F, Tanaka Y, Sanada M, Nannya Y, Tateishi K, Ohta M, Asaoka Y, Seto M, Imazeki F, Yoshida H, Ogawa S, Yokosuka O, Omata M. Prognostic significance of genetic alterations detected by high-density single nucleotide polymorphism array in gastric cancer. Cancer Sci. 2010 May;101(5):1261-9.

  44. Ito K, Arai M, Imazeki F, Yonemitsu Y, Bekku D, Kanda T, Fujiwara K, Fukai K, Sato K, Itoga S, Nomura F, Yokosuka O. Risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Scand J Gastroenterol. 2010;45(2):243-9.

  45. Ohno I, Eibl G, Odinokova I, Edderkaoui M, Damoiseaux RD, Yazbec M, Abrol R, Goddard WA 3rd, Yokosuka O, Pandol SJ, Gukovskaya AS. Rottlerin stimulates apoptosis in pancreatic cancer cells through interactions with proteins of the Bcl-2 family. Am J Physiol Gastrointest Liver Physiol. 2010 Jan;298(1):G63-73.

  46. Yan J, Yamaguchi T, Odaka T, Suzuki T, Ohyama N, Hara T, Sudo K, Nakamura K, Denda T, Takiguchi N, Yokosuka O, Nomura F. Stool antigen test is a reliable method to detect Helicobacter pylori in the gastric remnant after distal gastrectomy for gastric cancer. J Clin Gastroenterol. 2010 Jan;44(1):73-4.

  47. Aoki R, Chiba T, Miyagi S, Negishi M, Konuma T, Taniguchi H, Ogawa M, Yokosuka O, Iwama A. The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells. J Hepatol. 2010 Jun;52(6):854-63.

  48. Fujiwara K, Yasui S, Okitsu K, Yonemitsu Y, Oda S, Yokosuka O. The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis B. J Gastroenterol. 2010 Dec;45(12):1255-62.

  49. Matsumura T, Arai M, Yonemitsu Y, Maruoka D, Tanaka T, Suzuki T, Yoshikawa M, Imazeki F, Yokosuka O. The traditional Japanese medicine Rikkunshito increases the plasma level of ghrelin in humans and mice. J Gastroenterol. 2010 Mar;45(3):300-7.

  50. Sakai Y, Tsuyuguchi T, Ishihara T, Sugiyama H, Miyakawa K, Yasui S, Eto R, Fujimoto T, Ohtsuka M, Miyazaki M, Yokosuka O. Usefulness of peroral cholangioscopy in preoperative diagnosis of intraductal papillary neoplasm of the bile duct. Hepatogastroenterology. 2010 Jul-Aug;57(101):691-3.